000 02728nam  2200409zi 4500
0019.932229
003CaOODSP
00520240222102739
006m     o  d f      
007cr mn|||||||||
008240109e202108  onc     ob   f000 0 eng d
020 |a9780660695396
040 |aCaOODSP|beng|erda|cCaOODSP
0861 |aHP5-179/2024E-PDF
1001 |aPussegoda, Kusala, |eauthor.
24510|aEvidence brief of SARS-CoV-2 incubation periods.
2463 |aSummary of incubation periods
2463 |aCOVID-19 summary of incubation periods
264 1|aOttawa, ON : |bPublic Health Agency of Canada = Agence de la santé publique du Canada, |cAugust 2021.
264 4|c©2021
300 |a1 online resource (17 pages)
336 |atext|btxt|2rdacontent
337 |acomputer|bc|2rdamedia
338 |aonline resource|bcr|2rdacarrier
500 |aIssued also in French under title: Synthèse en bref sur les périodes d'incubation du SRAS-CoV-2.
500 |aCover title.
500 |a"Pub.: 230677"--Page 2.
500 |a"Prepared by: Kusala Pussegoda and Lisa Waddell, …"--Acknowledgements, page 7.
504 |aIncludes bibliographical references (pages 15-17).
520 |a"The incubation period is defined as the time between exposure to an infectious pathogen and symptom onset. The incubation period of SARS-CoV-2 determined by the World Health Organization (WHO) and the European Centers for Disease Control (ECDC) is 0-14.0 days, the US Centers for Disease Control and Prevention (CDC) is 2.0-14.0 days and the Public Health Agency of Canada is 1.0-14.0 days. A comparison across what was known on incubation periods for other coronaviruses reported the average incubation periods of SARS was 4.6 days (95% CI: 3.8-5.8 d) and MERS was 5.2 days (95% CI: 1.9-14.7 d). This review summarizes the incubation period of the original SARS-CoV-2 variants prior to the emergence of variants of concern (VOC) from several systematic reviews that included studies from the first 12 months of the pandemic and more recent research that has focused on establishing the incubation period of the VOCs. …"--Introduction, page 4.
650 0|aCOVID-19 (Disease)|xEpidemiology.
7102 |aPublic Health Agency of Canada, |eissuing body.
77508|tSynthèse en bref sur les périodes d'incubation du SRAS-CoV-2.|w(CaOODSP)9.932230
85640|qPDF|s661 KB|uhttps://publications.gc.ca/collections/collection_2024/aspc-phac/HP5-179-2024-eng.pdf
8564 |qHTML|sN/A|uhttps://www.canada.ca/en/public-health/services/diseases/2019-novel-coronavirus-infection/canadas-reponse/summaries-recent-evidence/evidence-brief-sars-cov-2-incubation-periods.html